Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics PLC | Chief Medical Officer | American Depositary Shares representing Ordinary Shares | 19.3K | $13K | $0.67 | Jan 17, 2024 | Direct |
Adaptimmune Therapeutics PLC | Chief Medical Officer | Option to purchase Ordinary Shares | 565K | Jan 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADAP | Adaptimmune Therapeutics PLC | Jan 16, 2024 | 3 | -$14.1K | 4 | Jan 17, 2024 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 15, 2024 | 2 | $0 | 4 | Jan 17, 2024 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 11, 2024 | 2 | -$10K | 4 | Jan 12, 2024 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 17, 2023 | 1 | -$4.01K | 4 | Jan 17, 2023 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 17, 2023 | 3 | $0 | 4 | Jan 17, 2023 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 11, 2023 | 2 | -$19.4K | 4 | Jan 12, 2023 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 4, 2023 | 1 | -$1.48K | 4 | Jan 4, 2023 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 18, 2022 | 1 | -$6.77K | 4 | Jan 18, 2022 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 12, 2022 | 2 | $0 | 4 | Jan 13, 2022 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 11, 2022 | 2 | -$16.4K | 4 | Jan 13, 2022 | Chief Medical Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 4, 2022 | 1 | -$3.45K | 4 | Jan 5, 2022 | Chief Medical Officer |